Ligand validation:7Q35

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7Q35_LFA_A_305	23%	98%	0.134	0.872	0.17	0.11	-	-	0	0	35%	0.35
7Q35_LFA_A_312	19%	91%	0.209	0.882	0.26	0.3	-	-	1	0	55%	0.297
7Q35_LFA_A_308	18%	94%	0.221	0.819	0.23	0.21	-	-	0	0	95%	0.931
7Q35_LFA_A_307	14%	98%	0.197	0.821	0.16	0.11	-	-	4	0	60%	0.6
7Q35_LFA_A_311	11%	94%	0.268	0.916	0.15	0.27	-	-	6	0	25%	10.75
7Q35_LFA_A_309	9%	98%	0.293	0.801	0.16	0.12	-	-	1	0	90%	0.45
7Q35_LFA_A_303	7%	95%	0.246	0.759	0.2	0.2	-	-	0	0	65%	0.65
7Q35_LFA_A_306	5%	98%	0.257	0.723	0.13	0.16	-	-	1	0	65%	0.65
7Q35_LFA_A_310	4%	97%	0.28	0.726	0.16	0.15	-	-	1	0	70%	0.539
7Q35_LFA_A_302	4%	94%	0.369	0.763	0.23	0.2	-	-	4	0	90%	0.738
7Q35_LFA_A_304	2%	98%	0.253	0.618	0.12	0.13	-	-	0	0	65%	0.65
7Z0D_LFA_A_801	47%	94%	0.095	0.949	0.26	0.2	-	-	0	0	35%	0.35
7Z0A_LFA_A_801	46%	76%	0.095	0.945	0.3	0.65	-	-	1	0	35%	0.35
7Z09_LFA_A_801	40%	76%	0.087	0.914	0.37	0.58	-	-	1	0	35%	0.35
7Q38_LFA_A_302	37%	98%	0.158	0.872	0.19	0.11	-	-	1	0	90%	0.45
4XXJ_LFA_A_313	31%	84%	0.14	0.897	0.24	0.52	-	-	1	0	50%	0.5
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	0	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.